Markets:

Overview

News

Currencies

International

Treasuries

Stryker Corp (NY:SYK)

339.76 -6.05 (-1.75%)

Official Closing Price Updated: 7:00 PM EDT, Mar 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Stryker Corp

< Previous 1 2 3 4 5 6 7 8 9

...

22 23 Next >

Q4 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Boston Scientific (NYSE:BSX)

February 10, 2025

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Boston Scientific (NYSE:BSX) and the best...

Via StockStory

Jim Cramer: This Health Care Stock Is A 'Winner,' Buy Bitcoin Instead Of Coinbase ↗

February 05, 2025

On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying AbbVie Inc. (NYSE:ABBV), saying it's “just a gem” and a “winner.” He added, “I can't believe the stock dropped so much.”

Via Benzinga

Stryker declares an $0.84 per share quarterly dividend

February 05, 2025

From Stryker Corporation

Via GlobeNewswire

$100 Invested In Stryker 10 Years Ago Would Be Worth This Much Today ↗

February 04, 2025

Via Benzinga

A Glimpse Into The Expert Outlook On Stryker Through 14 Analysts ↗

January 29, 2025

Via Benzinga

Stryker Earnings Report: Q4 Overview ↗

January 28, 2025

Via Benzinga

Stryker Earnings Review: Q4 Summary ↗

January 28, 2025

Via Benzinga

Stryker (NYSE:SYK) Posts Better-Than-Expected Sales In Q4

January 31, 2025

Medical technology company Stryker (NYSE:SYK) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 10.7% year on year to $6.44 billion. Its non-GAAP profit of $4.01 per...

Via StockStory

Stryker's Strategic Moves Impress Analysts, Spine Implant Sale and NARI Deal Set to Drive Future Growth ↗

January 29, 2025

Wall Street analysts upgraded Stryker Corp (NYSE: SYK) after its Q4 report beat expectations, with strong sales and earnings growth projected for 2025.

Via Benzinga

Starbucks To Rally Over 23%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

January 29, 2025

Via Benzinga

US Futures Point To Cautious Start As Investors Await Fed's Rate Decision: Tesla, Microsoft, Meta Among Stocks In Focus Ahead Of Earnings ↗

January 29, 2025

U.S. stock futures were mixed ahead of the crucial earnings from key U.S. technology companies and the Fed's expected pause on rate cuts.

Via Benzinga

Topics Economy

Stryker Earnings Analysis: Q4 Recap ↗

January 28, 2025

Via Benzinga

Stryker Q4 Earnings Assessment ↗

January 28, 2025

Via Benzinga

Insights into Stryker Q4 Earnings ↗

January 28, 2025

Via Benzinga

Tesla, Starbucks And 3 Stocks To Watch Heading Into Wednesday ↗

January 29, 2025

Via Benzinga

Stryker Undercuts Breakout On Sales Deal, Despite Quarterly Beat ↗

January 28, 2025

Stryker stock dipped late Tuesday after the medtech company beat forecasts, but announced its plan to divest the U.S. spinal business.

Via Investor's Business Daily

Earnings Summary: Stryker Q4 ↗

January 28, 2025

Via Benzinga

Stryker announces the retirement of Glenn S. Boehnlein and the promotion of Preston Wells to Vice President, Chief Financial Officer

January 28, 2025

From Stryker Corporation

Via GlobeNewswire

Stryker announces definitive agreement for the sale of its U.S. spinal implants business and plans to sell related international business

January 28, 2025

From Stryker Corporation

Via GlobeNewswire

If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today ↗

January 17, 2025

Via Benzinga

How Is The Market Feeling About Stryker? ↗

January 17, 2025

Via Benzinga

Stryker reports 2024 operating results and 2025 outlook

January 28, 2025

From Stryker Corporation

Via GlobeNewswire

Earnings Scheduled For January 28, 2025 ↗

January 28, 2025

Via Benzinga

Stryker commences tender offer for all outstanding shares of common stock of Inari Medical, Inc.

January 17, 2025

From Stryker Corporation

Via GlobeNewswire

Stryker Had A Good Year Last Year; Here's How It's Looking For 2025 ↗

January 13, 2025

Reflecting its strong growth, on Monday the Relative Strength (RS) Rating for Stryker stock got an upgrade from 70 to 74.

Via Investor's Business Daily

Plug Power, Capri And Frontline Are Among Top Mid Cap Gainers Last Week (Jan 6-10): Are The Others In Your Portfolio? ↗

January 12, 2025

These mid-cap stocks had impressive gains last week, including Inari Medical, Unifirst Corporation, and Walgreens. Are they in your portfolio?

Via Benzinga

Stryker To Buy Inari Medical In $5 Billion Deal To Bolster Venous Thromboembolism Position ↗

January 07, 2025

Stryker acquires Inari Medical in a $4.9 billion deal, enhancing its vascular portfolio with innovative VTE treatments and a growing global reach.

Via Benzinga

Why Inari Medical Shares Are Trading Higher By 21%; Here Are 20 Stocks Moving Premarket ↗

January 07, 2025

Via Benzinga

Stryker announces definitive agreement to acquire Inari Medical, Inc., providing entry into high-growth peripheral vascular segment

January 06, 2025

From Stryker Corporation

Via GlobeNewswire

Inari Medical Catapults 30% On Rumored Stryker Takeover ↗

January 06, 2025

Inari is best-known for its series of catheter-like devices that remove blood clots.

Via Investor's Business Daily

< Previous 1 2 3 4 5 6 7 8 9

...

22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.